Autres langues Cell Source, Inc.

Actions

CLCS

US15114L1044

Marché Fermé - OTC Markets Autres places de cotation 18:54:58 09/05/2024			Varia. 5j.	Varia. 1 janv.
0,0008 ^USD	+300,00%		0,00%	-99,83%

2023	Cell Source, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 30 septembre 2023	CI
2023	Cell Source, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cell Source, Inc. announced that it has received $4.76017 million in funding	22/03
Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Cell Source, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	19/09/23
Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/08/23
Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	08/08/23
Note 2 - Going Concern and Management Plans	08/12/22
Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	08/12/22
Note 2 - Going Concern and Management Plans	02/12/22
Cell Source, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	02/12/22
Note 2 - Going Concern and Management Plans	02/11/22
Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	02/11/22
CELL SOURCE, INC. : Change in Directors or Principal Officers (form 8-K)	21/07/22
Cell Source, Inc. Announces Board Resignations	21/07/22
CELL SOURCE, INC. : Change in Directors or Principal Officers (form 8-K)	06/05/22
Cell Source, Inc. Announces Resigation of Itamar Shimrat as A Director	06/05/22
CELL SOURCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	15/04/22
Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/04/22
Cell Source, Inc. Auditor Raises 'Going Concern' Doubt	15/04/22
Cell Source, Inc. Appoints George Verstraete as Member	11/03/22
CELL SOURCE, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers (form 8-K)	11/03/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cell Source, Inc.

Actions

CLCS

US15114L1044

Autres langues

Filtres